DJIA 18,126.12 -36.87 -0.20%
NASDAQ 5,097.98 -8.62 -0.17%
S&P 500 2,120.79 -2.69 -0.13%
market minute promo

3.99 -0.03 (-0.62%)

REAL-TIME: Last trade at

Extended Hours: $3.99 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ARNA $3.99 -0.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.00
Previous Close $4.01
Daily Range $3.90 - $4.02
52-Week Range $3.26 - $6.59
Market Cap $964.5M
P/E Ratio -15.42
Dividend (Yield) $0.00 (0.0%)
Volume 2,199,250
Average Daily Volume 2,844,772
Current FY EPS -$0.51




Drug Makers

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website:

News & Commentary

Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker

A double dose of bad news for the obesity drugmaker.

Orexigen Therapeutics: Contrave Not Surrendering Weekly Growth

Arena Pharmaceuticals: Hopes For Long-Term Value From Belviq Get A Lift From Congress

Vivus: Qsymia Sales Flatten Again - Third Place Out Of 3 Drugs Nothing To Celebrate

Arena: Belviq Sales Take Big Step Back - Advertising Needed

Orexigen: Contrave Sales Flattening - Europe Needed To Spur Numbers

Vivus: Qsymia Sales Win The Week, But Is It Enough?

Arena Pharmaceuticals In Good Shape Despite Flat Week In Prescriptions

Which of These Growth Stocks Is Most Worthy of Your Money?

Amarin Corp. and Arena Pharmaceuticals were once high-flying biotech stocks. Since the commercial launch of their respective flagship products, though, their shares have fallen in a big way. In this article, I consider which stock has the better chance of recapturing its former glory going forward.

Orexigen Plummets After Release Of 50% Interim Results, But Is This The End?

See More ARNA News...

ARNA's Top Competitors

ARNA $3.99 (-0.62%)
Current stock: ARNA
AMGN $157.35 (-1.93%)
Current stock: AMGN
GILD $112.85 (0.35%)
Current stock: GILD
BIIB $400.10 (-0.70%)
Current stock: BIIB